Position in GRAL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,334,921
-$733,000 QoQ
Shares Held
48,849
+2.8% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 374 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $75,057,898 across 14 Diagnostics & Research names. GRAL ranks #12 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
25,040 | $9,391,001 | |
| 2 | ICLR |
Icon PLC
|
53,631 | $9,316,241 | |
| 3 | DHR |
Danaher Corp /De/
|
42,993 | $8,189,306 | |
| 4 | BLLN |
BillionToOne, Inc.
|
57,000 | $6,838,860 | |
| 5 | A |
Agilent Technologies, Inc.
|
50,114 | $6,656,642 | |
| 6 | QGEN |
Qiagen N.V.
|
163,845 | $6,406,339 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
4,895 | $6,253,411 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
10,336 | $5,182,056 |
All Filings in GRAL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,334,921 | 48,849 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $4,067,921 | 47,528 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,831,551 | 30,975 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||